Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 1
1954 1
1955 5
1956 4
1957 11
1958 5
1959 3
1960 4
1961 4
1962 12
1963 9
1964 9
1965 18
1966 14
1967 13
1968 18
1969 12
1970 12
1971 11
1972 10
1973 17
1974 5
1975 27
1976 12
1977 15
1978 23
1979 23
1980 16
1981 23
1982 23
1983 46
1984 50
1985 39
1986 68
1987 60
1988 58
1989 85
1990 81
1991 83
1992 61
1993 74
1994 61
1995 63
1996 76
1997 74
1998 88
1999 88
2000 82
2001 66
2002 94
2003 81
2004 116
2005 126
2006 172
2007 174
2008 181
2009 194
2010 186
2011 214
2012 204
2013 206
2014 253
2015 275
2016 272
2017 244
2018 210
2019 231
2020 278
2021 67
Text availability
Article attribute
Article type
Publication date

Search Results

4,981 results
Results by year
Filters applied: . Clear all
Page 1
Essential Thrombocythemia.
Tefferi A, Pardanani A. Tefferi A, et al. N Engl J Med. 2019 Nov 28;381(22):2135-2144. doi: 10.1056/NEJMcp1816082. N Engl J Med. 2019. PMID: 31774958 Review. No abstract available.
Polycythemia vera and essential thrombocythemia: algorithmic approach.
Vannucchi AM, Guglielmelli P, Tefferi A. Vannucchi AM, et al. Curr Opin Hematol. 2018 Mar;25(2):112-119. doi: 10.1097/MOH.0000000000000402. Curr Opin Hematol. 2018. PMID: 29194068 Review.
SUMMARY: The revised 2017 WHO classification of polycythemia vera and essential thrombocythemia allows early diagnosis and accurate distinction from other chronic myeloproliferative neoplasms, particulary prefibrotic myelofibrosis. The prognostic value of selected m …
SUMMARY: The revised 2017 WHO classification of polycythemia vera and essential thrombocythemia allows early diagnosis and acc …
Developments in diagnosis and treatment of essential thrombocythemia.
Mora B, Passamonti F. Mora B, et al. Expert Rev Hematol. 2019 Mar;12(3):159-171. doi: 10.1080/17474086.2019.1585239. Epub 2019 Mar 13. Expert Rev Hematol. 2019. PMID: 30793984 Review.
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by thrombocytosis, increased risk of thrombotic/hemorrhagic events and clonal evolution into blast phase or myelofibrosis. ...An accurate molecular-morphologic assessment is necess
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by thrombocytosis, increased risk of thr
Current management strategies for polycythemia vera and essential thrombocythemia.
Guglielmelli P, Vannucchi AM. Guglielmelli P, et al. Blood Rev. 2020 Jul;42:100714. doi: 10.1016/j.blre.2020.100714. Epub 2020 Jun 3. Blood Rev. 2020. PMID: 32546373 Review.
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms characterized by increased rate of cardiovascular events, a varying burden of symptoms, and an intrinsic risk of evolution to secondary forms of myelofibrosis and acute leukem …
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms characterized by increased rate of …
Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery.
Chuzi S, Stein BL. Chuzi S, et al. Leuk Lymphoma. 2017 Dec;58(12):2786-2798. doi: 10.1080/10428194.2017.1312371. Epub 2017 May 15. Leuk Lymphoma. 2017. PMID: 28503969 Review.
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm that is associated with diminished quality of life, thrombohemorrhagic complications, and transformation to myelofibrosis (MF) and acute leukemia (AML). ...
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm that is associated with diminished quality of life, th
Contemporary approach to essential thrombocythemia and polycythemia vera.
Aruch D, Mascarenhas J. Aruch D, et al. Curr Opin Hematol. 2016 Mar;23(2):150-60. doi: 10.1097/MOH.0000000000000216. Curr Opin Hematol. 2016. PMID: 26717193 Review.
PURPOSE OF REVIEW: Management of polycythemia vera and essential thrombocythemia requires understanding of the key concepts regarding diagnosis, risk stratification, and management. RECENT FINDINGS: Essential thrombocythemia and polycythemia vera are a …
PURPOSE OF REVIEW: Management of polycythemia vera and essential thrombocythemia requires understanding of the key concepts re …
Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.
Maleknia M, Shahrabi S, Ghanavat M, Vosoughi T, Saki N. Maleknia M, et al. Mol Biol Rep. 2020 Jun;47(6):4767-4778. doi: 10.1007/s11033-020-05536-x. Epub 2020 May 30. Mol Biol Rep. 2020. PMID: 32472297 Review.
Essential thrombocythemia (ET) is a classical myeloproliferative neoplasm that is susceptible to hypercoagulable state due to impaired hemostatic system, so that thrombotic complications are the leading cause of mortality in ET patients. The content used in this art
Essential thrombocythemia (ET) is a classical myeloproliferative neoplasm that is susceptible to hypercoagulable state due to
Essential thrombocythemia.
Harrison CN, Green AR. Harrison CN, et al. Hematol Oncol Clin North Am. 2003 Oct;17(5):1175-90, vii. doi: 10.1016/s0889-8588(03)00082-0. Hematol Oncol Clin North Am. 2003. PMID: 14560781 Review.
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet no pathognomonic diagnostic test, and patients who currently fall into the category of essential thrombocythemia are likely to
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet n
Essential thrombocythemia.
Finazzi G, Harrison C. Finazzi G, et al. Semin Hematol. 2005 Oct;42(4):230-8. doi: 10.1053/j.seminhematol.2005.05.022. Semin Hematol. 2005. PMID: 16210036 Review.
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. ...
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philad …
Essential thrombocythemia.
Schafer AI. Schafer AI. Prog Hemost Thromb. 1991;10:69-96. Prog Hemost Thromb. 1991. PMID: 2008534 Review. No abstract available.
4,981 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page